Kala Subramanian
Senior Vice President, Strategic Development and O
Pharmaceuticals
CRISPR Therapeutics
Switzerland
Biography
Dr. Kala Subramanian has extensive experience in Strategic Planning, Portfolio and Program management across early and late stage development in Oncology and other therapeutic areas. In her most recent position, Kala was Vice President and Global Head of Strategic Development & Program Management at Novartis Pharmaceuticals (Oncology), where she was responsible for program and portfolio management, strategic planning, resource allocation and management of budget. She was also responsible for the integration of GSK Oncology into Novartis including full alignment of the portfolio, organization & people. Before that, Kala was in program management at Millennium and a senior consultant at Accenture. Kala received her PhD in Physical Chemistry from Cornell University and was a post-doctoral fellow at Duke University Medical Center.
Research Interest
Pharmaceutical Sciences
